You Don’t Outgrow ADHD 🧠 Here’s What Science Says | Prof. Stephen Faraone

Описание: ADHD is still a topic surrounded by myths and oversimplifications. In this episode, Dr Jarosław Jóźwiak talks to Prof. Stephen Faraone – one of the most highly cited ADHD researchers in the world – about the latest scientific findings in ADHD research.

👉 Is ADHD inherited? How old are ADHD risk genes? Are they becoming more or less common over time? What do we really know about the adverse effects of ADHD medications? Which treatment and therapy options are most effective for people with ADHD? 🧠

In this episode, Professor Stephen Faraone explains:
➡️ the role of genetics in ADHD
➡️ how advances in the biology of ADHD are changing treatment approaches
➡️ whether ADHD can be diagnosed using genetic testing
➡️ whether ADHD is a disorder and what the term “neurodiversity” actually means
➡️ whether stimulant medications for ADHD are safe
➡️ why ADHD treatment involves much more than medication alone
➡️ whether untreated ADHD can be dangerous

👉 Stephen Faraone is a distinguished Professor of Psychiatry as well as Neurobiology and Physiology at the Norton College of Medicine, SUNY Upstate Medical University in Syracuse, New York. He is also a Senior Scientific Advisor to the Pediatric Psychopharmacology Research Program at Massachusetts General Hospital and a Lecturer at Harvard Medical School. Prof. Faraone is the Program Director of the educational websites www.adhdinadults.com and www.ADHDevidence.org, and the President of the World Federation of ADHD.

👉 Stephen Faraone is ranked among the top 0.01% most cited scientists across all disciplines worldwide. In 2025, ScholarGPS recognized him as the world’s leading scientist in ADHD, and in 2024 ExpertScape ranked him as the top global expert in ADHD and behavioral disorders.
In 2023, Research.com also ranked him 80th among the world’s top scientists and 57th in the United States.

He is the recipient of numerous prestigious awards, including a Lifetime Achievement Award from the International Society of Psychiatric Genetics and the Paul Hoch Award from the American College of Neuropsychopharmacology.

➡️ ADHD RESEARCH DISCUSSED:
1. Genome-wide analyses of ADHD identify 27 risk loci, refine the genetic architecture and implicate several cognitive domains. Nature Genetics, 2023.
https://pmc.ncbi.nlm.nih.gov/articles...
2. Genomic analysis of the natural history of attention-deficit/hyperactivity disorder using Neanderthal and ancient Homo sapiens samples. Scientific Reports, 2020.
https://doi.org/10.1038/s41598-020-65...
3. Attention-Deficit/Hyperactivity Disorder Medications and Long-Term Risk of Cardiovascular Diseases. JAMA Psychiatry, 2024.
https://jamanetwork.com/journals/jama...
4. Methylphenidate and Short-Term Cardiovascular Risk. JAMA Network Open, 2024.
https://jamanetwork.com/journals/jama...
5. Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis. The Lancet Psychiatry, 2025.
https://doi.org/10.1016/S2215-0366(24...

The MTA Cooperative Group. A 14-Month Randomized Clinical Trial of Treatment Strategies for Attention-Deficit/Hyperactivity Disorder. Archives of General Psychiatry, 1999.
https://doi.org/10.1001/archpsyc.56.1...

#ADHD #ADHDAwareness #ADHDSupport

⸻